Address: C76, Balewadi, Pune, Maharashtra
According to a study published by Insure Insights, the global cannabidiol market is expected to grow at a CAGR of 24.5% during the forecast period. Cannabidiol is generally used for seizure disorder (epilepsy). It is also used for the treatment of anxiety, pain, a muscle disorder called dystonia, Parkinson disease, Crohn disease, and many other conditions. Cannabidiol has effects on the brain. It prevents the breakdown of a chemical in the brain that affects pain, mood, and mental function. Minimizing the breakdown of this chemical and increasing its blood levels helps to reduce psychotic symptoms associated with conditions such as schizophrenia. CBD has been proven to modify circuits in the brain related to drug addiction.
Top Driver: Growing Acceptance and Legalization of Cannabis Across Numerous Countries
Growing acceptance and legalization of cannabis across numerous countries such as Colombia, Australia, Chile, Germany, France, and Spain have highly propelled the global cannabidiol market. Countries are abundantly using CBD for the treatment of diseases such as chronic pain, cancer, multiple sclerosis, and depression. Moreover, as the FDA has allowed commercializing CBD oil, several companies have begun to sell these oils on various e-commerce sites and in retail stores. Countries that have decriminalized the use of cannabis are encountering a progression in the economy. As a result, more and more countries are spending in the cannabis industry.
B2C Segment Accounts for the Largest Market Share
The cannabidiol market is segmented into Business to Consumer (B2C) and Business to Business (B2B) based on the distribution channel. The B2C segment includes hospital pharmacies, online stores, and retail pharmacies. The B2C segment accounted for the highest revenue share and is expected to grow at a significant rate over the forecast period. The easy availability of these products to the consumers is one of the major factors driving the growth of this segment. In addition to this, increased acceptance of CBD oil and tinctures for personal and medical use available through pharmacies, retail stores, and online stores is expected to drive the growth of this segment during the forecast period. Based on the Source, the market is segmented into hemp and marijuana. Based on the end-use, the market is segmented into medical, personal use, pharmaceuticals, and others.
Increasing Decriminalization of Medical Cannabis to Benefit North America Market
North America accounted for the largest market share and will continue to the trend in the forecast period. The increasing decriminalization of medical cannabis in independent states of the U.S., the liberalism of government regulations concerning the same, and an overall increase in the adoption of cannabidiol for pharmaceutical, personal use, and wellness are some of the major factors driving the growth of the region.
Players to Focus on Collaboration and Expanding Product Portfolio
The major player operating in the global cannabidiol market are Isodiol, Medical Marijuana Inc., CV Sciences, Aurora Cannabis, Canopy Growth Corporation, NuLeaf Naturals, Tilray, Green Roads, GW Pharmaceuticals, Folium Biosciences, Medterra, Charlotte’s Web – CW Hemp, Endoca, Elixinol and Gaia Herbs, LLC.
Isodiol: In October 2019, Isodiol reported that it has entered into a strategic partnership with Vitamin Shoppe for the commercial release of Iso-Sport Products. This partnership was focused at expanding its cannabidiol hemp extract product portfolio for meeting the increasing customer demand.
CV Sciences: In November 2019, CV Sciences reported a new partnership with Southeastern Grocers to launch cannabidiol oil Plus brand that compromise topical as well as dietary products. The objective for the partnership was to increase availability and distribution of company’s best-selling PlusCBD oil products.
Scope of the Report
By Source Type
By Distribution Channel
By End-User
By Region
Key Reasons to Purchase this Report
Table of Content
Chapter 2 Our Research Practice
Chapter 4 Covid-19 Impact Analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Sepsis Diagnostic Market Forces
5.2 Porter’s Five Forces Analysis
5.2.2 Threats From New Entrants
5.2.4 Threat From Substitute Product
Chapter 6 Global Sepsis Diagnostic Market -Industry Snapshots
6.1.1 Global Sepsis Diagnostic Market Value, 2019 – 2028, (US$ Bn)
6.2.2 Restraint/Challenges analysis
6.3 Supply Chain/Value Chain Analysis
Chapter 7 Global Sepsis Diagnostic Market Analysis, by Technology
7.2 Key Findings for Sepsis Diagnostic Market- By Technology
7.2.1 Sepsis Diagnostic Market- Molecular diagnostic
7.2.2 Sepsis Diagnostic Market- Immunoassay
7.2.3 Sepsis Diagnostic Market- Microbiology
7.2.4 Sepsis Diagnostic Market- Others
Chapter 8 Global Sepsis Diagnostic Market Analysis, by Product
8.2 Key Findings for Sepsis Diagnostic Market- By Product
8.2.1 Sepsis Diagnostic Market- Instruments
8.2.2 Sepsis Diagnostic Market- Assay kits
8.2.3 Sepsis Diagnostic Market- Blood culture media
8.2.4 Sepsis Diagnostic Market- Others
Chapter 9 Global Sepsis Diagnostic Market Analysis, by Diagnostic method
9.2 Key Findings for Sepsis Diagnostic Market- By Diagnostic method
9.2.1 Sepsis Diagnostic Market- Laboratory testing
9.2.2 Sepsis Diagnostic Market- PoC testing
Chapter 10 Global Sepsis Diagnostic Market Analysis, by Pathogen
10.2 Key Findings for Sepsis Diagnostic Market- By Pathogen
10.2.1 Sepsis Diagnostic Market- Fungal sepsis
10.2.2 Sepsis Diagnostic Market- Bacterial sepsis
10.2.3 Sepsis Diagnostic Market- Others
Chapter 11 Sepsis Diagnostic Market Analysis by Region
11.1 Key Findings for Sepsis Diagnostic Market- By region
11.2.1 Global Sepsis Diagnostic Market Analysis, By Technology, 2019 – 2028
11.2.2 Global Sepsis Diagnostic Market Analysis, By Product, 2019 – 2028
11.2.3 Global Sepsis Diagnostic Market Analysis, By Diagnostic method, 2019 – 2028
11.2.4 Global Sepsis Diagnostic Market Analysis, By Pathogen, 2019 – 2028
11.3 Sepsis Diagnostic Market – North America
11.3.5 North America Market, By Technology
11.3.6 North America Market, By Product
11.3.7 North America Market, By Diagnostic method
11.3.8 North America Market, By Pathogen
11.4 Sepsis Diagnostic Market – Europe
11.4.7 Europe Market, By Technology
11.4.8 Europe Market, By Product
11.4.9 Europe market by, Diagnostic method
11.4.10 Europe Market, By Pathogen
11.5 Sepsis Diagnostic Market – Asia Pacific
11.5.6 Asia Pacific Market, By Technology
11.5.7 Asia Pacific Market, By Product
11.5.8 Asia Pacific Market, By Diagnostic method
11.5.9 Asia Pacific Market, By Pathogen
11.6 Sepsis Diagnostic Market – SAMEA
11.6.2 Middle East & Africa (MEA)
11.6.5 South America, Middle East and Africa Market, By Technology
11.6.6 South America, Middle East and Africa Market, By Product
11.6.7 South America, Middle East and Africa Market, By Diagnostic method
11.6.8 South America, Middle East and Africa Market, By Pathogen
Chapter 12 Market Competition Analysis
12.1 Market Share/Positioning Analysis
12.1.1 Market Positioning of Key Vendors, 2019
12.1.2 Key Strategies Adopted by the Leading Players
Chapter 13 Company Profiles- Snapshot
13.3 Becton, Dickinson and Company
13.6 Thermo Fisher Scientific, Inc.
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies”
Please fill out the form to receive sample pages of the report